Literature DB >> 8968395

Inhibition of plasminogen activator inhibitor-1 activity by two diketopiperazines, XR330 and XR334 produced by Streptomyces sp.

J Bryans1, P Charlton, I Chicarelli-Robinson, M Collins, R Faint, C Latham, I Shaw, S Trew.   

Abstract

Two diketopiperazines, XR334 (1) and the novel compound XR330 (2), were isolated from the lyophilised biomass of an unidentified Streptomyces sp. Their structures were elucidated on the basis of spectroscopic studies and confirmed by chemical synthesis. Both compounds inhibited plasminogen activator inhibitor-1 activity in an amidolytic assay of tissue plasminogen activator mediated plasmin generation. Compound 1 also enhanced fibrinolysis ex vivo and protected against thrombus formation in the rat. These diketopiperazines represent the first low molecular weight inhibitors of plasminogen activator inhibitor-1, a physiological regulator of fibrinolysis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968395     DOI: 10.7164/antibiotics.49.1014

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  8 in total

1.  New diketopiperazine derivatives with cytotoxicity from Nocardiopsis sp. YIM M13066.

Authors:  Mingwei Sun; Xiaotong Chen; Wenjun Li; Chunhua Lu; Yuemao Shen
Journal:  J Antibiot (Tokyo)       Date:  2017-04-05       Impact factor: 2.649

Review 2.  Solid-phase and microwave-assisted syntheses of 2,5-diketopiperazines: small molecules with great potential.

Authors:  Jennifer C O'Neill; Helen E Blackwell
Journal:  Comb Chem High Throughput Screen       Date:  2007-12       Impact factor: 1.339

3.  Low Molecular Weight Antagonists of Plasminogen Activator Inhibitor-1: Therapeutic Potential in Cardiovascular Disease.

Authors:  Tessa M Simone; Paul J Higgins
Journal:  Mol Med Ther       Date:  2012-08-05

Review 4.  Fibrinolytic System and Cancer: Diagnostic and Therapeutic Applications.

Authors:  Niaz Mahmood; Shafaat A Rabbani
Journal:  Int J Mol Sci       Date:  2021-04-22       Impact factor: 5.923

5.  Chemical Antagonists of Plasminogen Activator Inhibitor-1: Mechanisms of Action and Therapeutic Potential in Vascular Disease.

Authors:  Tessa M Simone; Stephen P Higgins; Craig E Higgins; Michelle R Lennartz; Paul J Higgins
Journal:  J Mol Genet Med       Date:  2014-10

Review 6.  An update on 2,5-diketopiperazines from marine organisms.

Authors:  Ri-Ming Huang; Xiang-Xi Yi; Yuying Zhou; Xiangdong Su; Yan Peng; Cheng-Hai Gao
Journal:  Mar Drugs       Date:  2014-12-19       Impact factor: 5.118

7.  Bioactivity-Guided Fractionation of the Traditional Chinese Medicine Resina Draconis Reveals Loureirin B as a PAI-1 Inhibitor.

Authors:  Yu Jiang; Guangping Zhang; Dong Yan; Hong Yang; Zuguang Ye; Tonghui Ma
Journal:  Evid Based Complement Alternat Med       Date:  2017-09-18       Impact factor: 2.629

8.  Inhibition of PAI-1 Activity by Toddalolactone as a Mechanism for Promoting Blood Circulation and Removing Stasis by Chinese Herb Zanthoxylum nitidum var. tomentosum.

Authors:  Bo Yu; Guangping Zhang; Lingling Jin; Bo Zhang; Dong Yan; Hong Yang; Zuguang Ye; Tonghui Ma
Journal:  Front Pharmacol       Date:  2017-07-21       Impact factor: 5.810

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.